Cullinan Associates’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$222K Hold
13,200
0.02% 201
2025
Q4
$252K Hold
13,200
0.02% 201
2025
Q3
$301K Sell
13,200
-5,500
-29% -$139K 0.02% 191
2025
Q2
$566K Hold
18,700
0.04% 163
2025
Q1
$640K Hold
18,700
0.05% 151
2024
Q4
$545K Sell
18,700
-1,500
-7% -$50.5K 0.04% 166
2024
Q3
$738K Hold
20,200
0.04% 162
2024
Q2
$676K Sell
20,200
-200
-1% -$7.37K 0.04% 168
2024
Q1
$872K Hold
20,400
0.05% 160
2023
Q4
$789K Hold
20,400
0.04% 161
2023
Q3
$770K Hold
20,400
0.04% 157
2023
Q2
$929K Hold
20,400
0.05% 163
2023
Q1
$827K Hold
20,400
0.05% 167
2022
Q4
$1.04M Buy
20,400
+2,500
+14% +$134K 0.06% 158
2022
Q3
$964K Sell
17,900
-125
-0.7% -$7.52K 0.06% 145
2022
Q2
$1.16M Hold
18,025
0.07% 135
2022
Q1
$1.4M Sell
18,025
-50
-0.3% -$4.19K 0.07% 132
2021
Q4
$1.55M Hold
18,075
0.08% 129
2021
Q3
$1.45M Hold
18,075
0.08% 131
2021
Q2
$1.46M Buy
18,075
+1,500
+9% +$126K 0.08% 131
2021
Q1
$1.4M Buy
16,575
+1,750
+12% +$139K 0.08% 122
2020
Q4
$1.19M Buy
+14,825
New +$1.17M 0.07% 124
2016
Q2
Sell
-25,195
Closed -$1.03M 203
2016
Q1
$1.03M Sell
25,195
-1,600
-6% -$61K 0.09% 128
2015
Q4
$1.02M Sell
26,795
-83,200
-76% -$3.04M 0.09% 129
2015
Q3
$3.61M Sell
109,995
-98,883
-47% -$3.74M 0.33% 69
2015
Q2
$7.93M Sell
208,878
-24,200
-10% -$905K 0.65% 35
2015
Q1
$8.67M Buy
233,078
+8,316
+4% +$315K 0.67% 31
2014
Q4
$8.95M Buy
224,762
+37,910
+20% +$1.48M 0.95% 17
2014
Q3
$7.28M Buy
186,852
+76,620
+70% +$3.11M 0.83% 23
2014
Q2
$4.15M Sell
110,232
-50,526
-31% -$2.02M 0.67% 23
2014
Q1
$6.42M Buy
160,758
+6,561
+4% +$245K 0.73% 26
2013
Q4
$5.83M Sell
154,197
-18,133
-11% -$658K 0.68% 27
2013
Q3
$6.15M Buy
172,330
+24,236
+16% +$941K 0.82% 20
2013
Q2
$5.57M Buy
+148,094
New +$5.67M 0.75% 22

Other funds holding BAX

Cullinan Associates's BAX Position: Q1 2026 in Review

Cullinan Associates held its Baxter International (BAX) position steady in Q1 2026 at 13,200 shares worth $222K. The position accounts for 0.02% of the portfolio, ranked #201.

Cullinan Associates first reported a position in BAX in Q2 2013 and has held it in 34 quarters since. The position peaked at $8.95M in Q4 2014. 657 funds tracked by Wall St. Rank hold BAX as of Q1 2026.

  • Cullinan Associates held 13,200 shares of Baxter International worth $222K as of Q1 2026.
  • Cullinan Associates left its Baxter International share count unchanged in Q1 2026.
  • Baxter International made up 0.02% of Cullinan Associates's portfolio in Q1 2026, its #201 holding.
  • Cullinan Associates first reported a position in Baxter International in Q2 2013 and has held it in 34 quarters since.
  • Cullinan Associates's Baxter International position peaked at $8.95M in Q4 2014.
  • 657 funds tracked by Wall St. Rank held Baxter International as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.